Rising technological advancements and the demand for personalized medicine have led to innovations in drug development and treatment strategies. Methotrexate is a medication commonly used in the treatment of various medical conditions, including cancer, autoimmune diseases, and rheumatoid arthritis. With the use of advancements in injectable technologies, methotrexate injections can be made more practical, secure, and patient-compliant. Better equipment, including auto-injectors and wearable injectors will be able to improve the patient experience and create potential for differentiation.
For instance, Atomwise utilizes artificial intelligence (AI) in drug discovery. MethoAI is an example of the way AI is used to design novel methotrexate derivatives with improved efficacy and reduced side effects, tailoring treatments to individual patient needs. Additionally, HealthTech Inc. offers a mobile app called MedMethoCare that helps patients track their methotrexate treatment, record symptoms, and receive personalized reminders and dosing instructions based on their health data and treatment response. Therefore, increasing technological advancements and product approvals are projected to accelerate industry expansion.